Roles of chemokine CXCL12 in bone growth defects induced by methotrexate and dexamethasone chemotherapeutic treatment
Year: 2017
Type: dissertation
Abstract: Methotrexate (MTX) and/or dexamethasone (Dex) are the two most commonly and intensively used agents in childhood oncology, particularly in acute lymphoblastic leukemia(ALL). However, intensive use of these chemotherapeutic agents is known to cause bone growth defects such as growth arrest, bone loss and fracture. Although the mechanisms for chemotherapy-induced bone growth defects still remain unclear, significant disruptions to cell population and interaction such as induced chondrocyte/osteocyte apoptosis accompanied b enhanced chondroclast/osteoclast recruitment and activity have been observed within bone and marrow microenvironment. However, potential molecular signals for the link between skeletal apoptosis and chondroclast/osteoclast recruitment are unclear. The current study addressed the potential roles of specific cytokine(s) and/or chemokine(s) induced by apoptotic chondrocytes/osteocytes in the chondroclast/osteoclast recruitment and bone defects following MTX and/or Dex treatment in vitro and in vivo.
Author: Tang, Qian,
Institution: University of South Australia
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7217350856
